- Home
- TARS vs UAA Comparison
TARS vs UAA Comparison
Compare TARS & UAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TARS | UAA |
|---|---|---|
| Founded | 2016 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.4B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | TARS | UAA |
|---|---|---|
| Price | $71.64 | $5.77 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 16 |
| Target Price | ★ $76.56 | $6.18 |
| AVG Volume (30 Days) | 709.0K | ★ 15.3M |
| Earning Date | 02-24-2026 | 02-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $366,100,000.00 | ★ $5,049,070,000.00 |
| Revenue This Year | $147.34 | N/A |
| Revenue Next Year | $53.50 | $1.46 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 182.44 | N/A |
| 52 Week Low | $38.51 | $4.13 |
| 52 Week High | $85.25 | $8.72 |
Technical Indicators
Market Signals| Indicator | TARS | UAA |
|---|---|---|
| Relative Strength Index (RSI) | 26.51 | 68.93 |
| Support Level | $76.91 | $5.39 |
| Resistance Level | $76.22 | $5.81 |
| Average True Range (ATR) | 3.15 | 0.29 |
| MACD | -1.09 | 0.04 |
| Stochastic Oscillator | 0.12 | 79.59 |
Price Performance
Historical ComparisonAbout TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
About UAA Under Armour Inc.
Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and Latin America. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through wholesale partners, company-owned digital channels, and approximately 450 company-owned outlet and full-price stores. The Baltimore-based firm was founded in 1996 and is led by controlling shareholder Kevin Plank.